ARCHIVES

EU Gives Marketing Approval For HBV Sequencing Test

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

October 22, 2004

FDA Policy On Support Of Medical Education Near Final Form

February 5, 1993

ACS Increases Funding for Scholar Grants; NCI Posts Interim FY2001 Funding Policy.

December 1, 2000

ACS Urged To Put More Resources Into Psychosocial Research

May 8, 1981

USPSTF Delivers “D” Recommendation For Ovarian Cancer Screening

September 28, 2012

DCT Board Okays Recompetitions

June 21, 1985